ABSTRACT This study was designed to test the hypothesis that verapamil has an effect on ischemiainitiated arrhythmias related to its regional influences on recovery of excitability and conduction time. Using a coronary perfused preparation of cat left ventricle that allows simultaneous electrophysiologic monitoring of both endocardium and epicardium, we studied the effect of verapamil on ischemiainduced changes in transmembrane action potentials, conduction properties, and refractory periods of endocardial and epicardial muscle cells. Oxygenated Tyrode's solution was perfused through the left anterior descending coronary artery, while the preparation was superfused with Tyrode's solution gassed with 95% N2 and 5% CO2. "Ischemia" was produced by stopping coronary perfusion. During 30 min of ischemia, resting potential, action potential amplitude (APA), and action potential duration (APD) were reduced, and conduction time was prolonged in both endocardial and epicardial cells, but the changes were greater in the epicardial cells. Endocardial refractory periods shortened in parallel with APD shortening throughout 30 min of ischemia, whereas epicardial refractory periods shortened for the first 10 min and then increased due to development of longer postrepolarization refractoriness. As a result, there were significant differences in refractory periods between endocardial and epicardial cells at 10 and 30 min of ischemia, and rapid ventricular activity could be induced at these times. Exposure to verapamil (1 mg/liter) before cessation of coronary perfusion significantly limited the reduction of APA and the prolongation of conduction time during the first 10 min of ischemia in epicardial cells, but did not influence endocardial cells. During the remaining 20 min of ischemia, verapamil enhanced the reduction of APD of both epicardial and endocardial cells. Verapamil abolished the significant differences in refractory period between endocardial and epicardial cells at 30 min of ischemia, because it enhanced ischemia-induced APD shortening to a greater degree in epicardial cells. Rapid ventricular activity was no longer inducible by extrastimuli at 30 min of ischemia in the presence of verapamil. These results lead us to suggest that verapamil may prevent some ischemic arrhythmias by limiting conduction disturbances and dispersion of endo-epicardial refractoriness. Our data also indicate that verapamil has multiple actions in the different regions of the heart under pathophysiologic conditions. Circulation 76, No. 5, 1146No. 5, -1154No. 5, , 1987 VERAPAMIL has been demonstrated to prevent or abolish arrhythmias occurring during experimental ischemia and reperfusion. l-3 Although the precise mechanism underlying this action is unclear, one possible explanation is that verapamil suppresses calciumdependent slow responses that may be generated in ischemic myocardium.4 5 However, recent studies 
VERAPAMIL has been demonstrated to prevent or abolish arrhythmias occurring during experimental ischemia and reperfusion. l-3 Although the precise mechanism underlying this action is unclear, one possible explanation is that verapamil suppresses calciumdependent slow responses that may be generated in ischemic myocardium.4 5 However, recent studies have shown that verapamil and other calcium-entry blockers also improve conduction disturbances induced by ischemia,68 and ventricular arrhythmias are suppressed along with an improvement of conduction disturbances.6 This salutary effect of verapamil on conduction disturbances in ischemic myocardium may be an indirect action related to increased blood supply to the ischemic zone mediated by dilation of collateral vessels. However, Nakaya and Kimura and their colleagues7-10 have demonstrated in a series of studies that verapamil and other calcium-entry blockers reduce ischemia-induced conduction disturbances by a direct action on ischemic myocardial cells.
We have recently developed a unique coronary perfused preparation of cat left ventricle that allows us to CIRCULATION simultaneously monitor the electrophysiologic changes in both endocardial and epicardial muscle cells during ischemia.i1' 12 We used this preparation to study the effect of verapamil on ischemia-induced changes in transmembrane action potentials, conduction properties, and refractory periods recorded simultaneously from endocardial and epicardial cells to gain insight into mechanisms of the salutary action of verapamil on ischemic arrhythmias. Our data lead us to suggest that verapamil alters ischemia-induced regional differences in action potential duration, refractory period, and conduction, independent of its effect on coronary flow.
Methods
Domestic cats of both sexes weighing 2.0 to 4.0 kg were anesthetized with sodium pentobarbital (30 mg/kg ip). The hearts were rapidly removed and immersed in cool oxygenated Tyrode's solution. The dissection, coronary perfusion, and superfusion techniques have been previously described in detail.11 ' 12 In brief, after removal of both atria and the right ventricle, the left anterior descending coronary artery was cannulated with a polyethylene cannula (diameter 0.038 inch) through the left main coronary ostium in the aortic root. An interval of no more than 5 min elapsed from the time the heart was excised to coronary cannulation. The cannulas were secured in place with 6-0 silk suture, and the preparations were perfused with Tyrode's solution equilibrated with 95% 02 and 5% CO2. The perfused area was distinctly delineated by its pale appearance after injection of Tyrode's solution. The tissue beyond the perfused area was excised, and the major branches of arteries transected by the dissection were ligated with 6-0 silk suture. After successful completion of the experimental protocol, Evans blue dye (Sigma) was injected to ensure that the preparations were well perfused. Data reduced and APD was shortened in both endocardial PAMIL (figure 1) and epicardial (figure 2) muscle cells. ventricular activity developed within 10 sec, as shown in figures 1, A, and 2, A. This rhythmic activity persisted for several seconds to a few minutes, and then stopped spontaneously. Transmembrane action potentials and conduction time returned to baseline within the next 5 min.
Changes in refractory periods during ischemia. Ischemia-induced changes in refractory periods of endocardial and epicardial muscle cells are shown in the left panel of figure 3 , B, and are summarized in table 3. During control periods, there were no differences in refractory periods measured on the endocardium and epicardium. During ischemia, endocardial refractory periods shortened progressively in parallel with APD shortening (left panels of figure 3) , and the magnitude od, but prolonged during the next 20 min of ischemia, because postrepolarization refractoriness lengthened. These changes in recovery of excitability resulted in significant differences in refractory periods between endocardial and epicardial cells at 10 and 30 min of ischemia ( figure 3, B data suggest that the improvement of APA and conduction disturbances, and the decrease in dispersion of refractoriness between endocardial and epicardial cells, also may be involved in the suppression of ischemic arrhythmias by verapamil. Therefore, the action of antiarrhythmic drugs may be multiple, and studies of their actions must not be limited to their most obvious direct pharmacologic effects. Furthermore, as suggested in this study, a single drug may express different actions in different regions of the heart.
